In this video interview, Dominique Demolle, CEO of Cognivia, highlights how patient non-adherence could increase trial ...

Clinical trial complexity has significantly increased in the past decade. How can the industry adapt and innovate to remain ...

The new Phase 2 clinical trial protocol focuses on a specific patient population (advanced, recurrent, platinum-resistant ovarian cancer patients) with limited treatment options, highlighting the ...

Oncology studies present unique challenges when it comes to participant treatment, resupply, and study management.

To avoid a tug-of-war between scientific rigour and operational efficiency, we must focus on the user and data journeys of ...

The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...

Nishit Agarwal exemplifies excellence in Biomedical AI and Signal Processing with extensive experience in developing ...

In an interview with Applied Clinical Trials Associate Editor Don Tracy, Samuel Salvaggio, Senior Trial Design Lead, ...

CEO Jim Frakes noted that Aethlon Medical has made significant progress in focusing on oncology and implementing cost reductions. Operating expenses were reduced by 50% compared to the same quarter ...

PHILADELPHIA, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company") is also pleased to announce that its phase 2 clinical study (SKNJCT-003) which is ...